EMA — authorised 26 August 2013
- Marketing authorisation holder: Novartis Europharm Limited
- Status: approved
🇪🇺 Tafinlar in European Union
EMA authorised Tafinlar on 26 August 2013
Marketing authorisation
Tafinlar in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Oncology approved in European Union
Frequently asked questions
Is Tafinlar approved in European Union?
Yes. EMA authorised it on 26 August 2013.
Who is the marketing authorisation holder for Tafinlar in European Union?
Novartis Europharm Limited holds the EU marketing authorisation.